[HTML][HTML] HPV vaccines–a review of the first decade
DM Harper, LR DeMars - Gynecologic oncology, 2017 - Elsevier
Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
[HTML][HTML] Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches
Skin cancer, including both melanoma and non-melanoma, is the most common type of
malignancy in the Caucasian population. Firstly, we review the evidence for the observed …
malignancy in the Caucasian population. Firstly, we review the evidence for the observed …
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
WK Huh, EA Joura, AR Giuliano, OE Iversen… - The Lancet, 2017 - thelancet.com
Background Primary analyses of a study in young women aged 16–26 years showed
efficacy of the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52 …
efficacy of the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52 …
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional …
K Kavanagh, KG Pollock, K Cuschieri… - The Lancet infectious …, 2017 - thelancet.com
Summary Background On Sept 1, 2008, Scotland launched routine vaccination for human
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …
Evidence for underuse of effective medical services around the world
Underuse—the failure to use effective and affordable medical interventions—is common and
responsible for substantial suffering, disability, and loss of life worldwide. Underuse occurs …
responsible for substantial suffering, disability, and loss of life worldwide. Underuse occurs …
Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries
L Denny, S de Sanjose, M Mutebi, BO Anderson, J Kim… - The Lancet, 2017 - thelancet.com
Breast and cervical cancers are the commonest cancers diagnosed in women living in low-
income and middle-income countries (LMICs), where opportunities for prevention, early …
income and middle-income countries (LMICs), where opportunities for prevention, early …
Prevalence of human papillomavirus among females after vaccine introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
SE Oliver, ER Unger, R Lewis… - The Journal of …, 2017 - academic.oup.com
Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm
Since being introduced in the 1940s, cervical cytology–despite its limitations–has had
unequivocal success in reducing cervical cancer burden in many countries. However, we …
unequivocal success in reducing cervical cancer burden in many countries. However, we …
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
N Wentzensen, M Arbyn, J Berkhof… - … Journal of Cancer, 2017 - Wiley Online Library
Human papillomaviruses (HPVs) are the necessary cause of most cervical cancers, a large
proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The …
proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The …